---
title: "03:29 ETInvitation to Vitrolife Group's presentation of the Q1 2026 interim report"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282152235.md"
description: "Vitrolife AB (publ) will release its Q1 2026 interim report on April 23, 2026, at 08:00 am CET. A conference call for investors and analysts will follow at 10:00 am CET, featuring CEO Bronwyn Brophy O'Connor and CFO Pär Ihrskog. The presentation will be in English, with a Q&A session afterward. Presentation materials will be available on the Vitrolife Group website prior to the call. Registration is required to participate in the conference call."
datetime: "2026-04-09T07:32:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282152235.md)
  - [en](https://longbridge.com/en/news/282152235.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282152235.md)
---

# 03:29 ETInvitation to Vitrolife Group's presentation of the Q1 2026 interim report

, /PRNewswire/ -- Vitrolife AB (publ) will publish its Q1 2026 interim report on Thursday, 23 April 2026 at 08:00 am CET. A conference call for investors, analysts and financial media will be held at 10:00 am CET the same day.

The presentation will be held in English by Bronwyn Brophy O'Connor, CEO, and Pär Ihrskog, CFO. The conference call will begin with a presentation of the report followed by a question-and-answer session. The presentation material will be available prior to the start of the conference call on the Vitrolife Group website www.vitrolifegroup.com.

To follow the webcast, please use this link.

To participate in the conference call please register via this link. After registration, you will be provided with telephone numbers and a conference ID to access the conference. You can ask questions verbally via the telephone conference.

After the event, the presentation material and a recording of the webcast will be available at www.vitrolifegroup.com.

Gothenburg, 9 April 2026  
VITROLIFE AB (publ)

**Contact:**  
Jenny Jakobson  
Investor Relations  
\[email protected\]

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/invitation-to-vitrolife-group-s-presentation-of-the-q1-2026-interim-report,c4331301

SOURCE Vitrolife AB (publ)

### Related Stocks

- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIS.US](https://longbridge.com/en/quote/BIS.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)

## Related News & Research

- [Avant Brands Reports Q1 2026 Results Highlighted by 37% Growth in Recreational Revenue | AVTBF Stock News](https://longbridge.com/en/news/282741678.md)
- [BUZZ-Cancer biotech Adlai Nortye jumps after $150 mln equity financing](https://longbridge.com/en/news/282996483.md)
- [Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year | CSTL Stock News](https://longbridge.com/en/news/282333053.md)
- [Tsingke Unveils 'Zero-Contact' Gene Synthesis to Safeguard Core Genetic Sequences](https://longbridge.com/en/news/282858902.md)
- [BUZZ-Precision BioSciences up as hepatitis B gene‑editing trial expands in Europe](https://longbridge.com/en/news/282832865.md)